Attovia Therapeutics, Inc. (ATTO)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$17.78−$0.3900 (−2.15%) on the dayAs of the close; data may be delayed.
ATTO price, last 12 months
Key stats
- Previous close
- $18.17
- Open
- $18.10
- Day range
- $17.61 – $19.35
- 52-week range
- $0.4248 – $28.00
- Volume
- 404.4K
- Avg volume (20 days)
- 330.9K
- Market cap
- $811.7M
Performance
1W−19.7%
1M−9.1%
3M+1,152.1%
6M+876.9%
YTD+3,670.9%
1Y+240.6%
vs S&P 500, 1Y+223.8 pts
Technicals and fundamentals
About Attovia Therapeutics, Inc.
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $811.7M